Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Action Pharma makes appointments

This article was originally published in Scrip

Executive Summary

Action Pharma, a privately owned Danish biotech company, has appointed Ingelise Saunders as its new chief executive officer. The company's former CEO, Søren Nielsen, becomes chief operating officer and continues as part of Action's executive management group. Ms Saunders was president and CEO of ACE BioSciences (Denmark) for five years. Before that, she served as CEO of Celltech Pharmaceuticals (UK) for three years and spent 16 years with Novo Nordisk in senior executive management positions, both in Denmark and the UK.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts